Shashi Kori

Shashi Kori is an accomplished pharmaceutical executive with extensive experience in clinical development and medical affairs. Currently serving as CEO of Novilla Pharmaceuticals since March 2019 and Chief Medical Officer of Trigemina, Inc. since August 2015, Shashi has led various critical initiatives in both roles. Previous positions include Chief Medical Officer at Autonomic Technologies Inc. and Vice President at Allergan Inc. and MAP Pharmaceuticals, where Shashi played a pivotal role in building a successful biotech company and leading significant clinical developments. Educational background includes a fellowship in Neuro-Oncology from Cornell University and an MD from Manipal Academy of Higher Education. Shashi's career also features leadership roles at GlaxoSmithKline Biologicals and Duke University, showcasing a strong foundation in the neurology field and collaborative interdisciplinary management.